Home › Funds › Nantahala Capital Management, LLC › EOLS
Nantahala Capital Management, LLC position in EOLS
EVOLUS INC · Health Care
Nantahala Capital Management, LLC reported holding 6,244,690 shares of EOLS (EVOLUS INC) in its Q3 2026 13F filing — a position valued at US$50.0M, representing 2.29% of its reported portfolio and ranking #6 among its reported holdings. Nantahala Capital Management, LLC has disclosed EOLS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nantahala Capital Management, LLC's EOLS position evolved
Nantahala Capital Management, LLC first disclosed a stake in EOLS in Q3 2023 at 421,220 shares (US$3.8M). The position peaked in Q3 2026 at 6,244,690 shares, worth US$50.0M. Across 13 filings, Nantahala Capital Management, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 6,244,690 shares valued at US$50.0M — an increase of 642,669 shares quarter over quarter.. Notable position changes include a 591% increase in Q4 2023 (shares rose 33% over the following quarter), a 97% trim in Q1 2025 (shares fell 23% over the following quarter), a 5627% increase in Q3 2025 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 421.22K | $3.85M | New |
| Q4 2023 | 2.91M | $30.65M | Add |
| Q1 2024 | 2.91M | $40.75M | Hold |
| Q2 2024 | 2.91M | $31.58M | Hold |
| Q3 2024 | 2.82M | $45.76M | Reduce |
| Q4 2024 | 3.13M | $34.56M | Add |
| Q1 2025 | 100.00K | $1.20M | Reduce |
| Q2 2025 | 100.00K | $921.00K | Hold |
| Q3 2025 | 5.73M | $35.16M | Add |
| Q4 2025 | 5.82M | $38.71M | Add |
| Q1 2026 | 6.38M | $26.21M | Add |
| Q2 2026 | 5.60M | $38.88M | Reduce |
| Q3 2026 | 6.24M | $49.96M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EOLS and 13F data
EOLS (EVOLUS INC) is a Health Care company. 22 other funds we track also report a position in EOLS — the largest reported positions include BRAIDWELL LP (US$21.9M), Frazier Life Sciences Management, L.P. (US$18.3M), Soviero Asset Management, LP (US$5.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EOLS
- BRAIDWELL LP 3.16M sh · $21.90M · Q2 2026
- Frazier Life Sciences Management, L.P. 2.63M sh · $18.26M · Q2 2026
- Soviero Asset Management, LP 770.00K sh · $5.34M · Q2 2026
- Stonepine Capital Management, LLC 500.00K sh · $5.00M · Q3 2026
More on Nantahala Capital Management, LLC
FAQ
How long has Nantahala Capital Management, LLC held EOLS?
Nantahala Capital Management, LLC has disclosed EOLS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nantahala Capital Management, LLC's current position in EOLS?
As of Q3 2026, Nantahala Capital Management, LLC holds 6.24M shares of EOLS (EVOLUS INC), valued at $49.96M, representing 2.29% of its reported portfolio and ranking #6.
Has Nantahala Capital Management, LLC been buying or selling EOLS?
In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in EOLS. The position peaked in Q3 2026 at 6.24M shares.
Which other funds hold EOLS?
Other major institutional holders of EOLS include BRAIDWELL LP, Frazier Life Sciences Management, L.P., Soviero Asset Management, LP, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.